Inderal-LA recall in Canada: nitrosamine impurity
In plain language
This recall involves Inderal-LA (propranolol hydrochloride) extended release capsules sold in Canada. It's being recalled because of a nitrosamine impurity (N-nitroso-propranolol) above acceptable levels. Continue taking your medication unless advised otherwise by your healthcare provider, and contact them to discuss other treatment options.
What to do
- Contact your healthcare provider to discuss other treatment options.
- Continue taking your medication unless advised to stop by your healthcare provider.
- Contact Pfizer Canada ULC for medical inquiries at 1-800-463-6001 or general inquiries at 1-800-387-4974.
- Report any health product-related side effects or complaints to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Inderal-LA 60 mg
Lot: DX6150, EH5907, EX7461
Date codes: 2023-03-31, 2023-08-31, 2024-01-31
Inderal-LA 80 mg
Lot: DJ2768, DW8242, EE7221, EL1695, EX7462
Date codes: 2022-09-30, 2023-03-31, 2023-05-31, 2023-08-31, 2024-01-31
Inderal-LA 120 mg
Lot: DJ6820, DX6159, EH5908, FE0541
Date codes: 2022-09-30, 2023-03-31, 2023-08-31, 2024-01-31
Inderal-LA 160 mg
Lot: DW8241, EH5906, FE6304
Date codes: 2023-03-31, 2023-08-31, 2024-01-31
Why this matters
Increased cancer risk from long-term exposure
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2022-09-30, 2023-03-31, 2023-05-31, 2023-08-31, 2024-01-31
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: DJ2768, DJ6820, DW8241, DW8242, DX6150, DX6159, EE7221, EH5906, EH5907, EH5908, EL1695, EX7461, EX7462, FE0541, FE6304
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Increased cancer risk from long-term exposure
What should consumers do?
Contact your healthcare provider to discuss other treatment options. Continue taking your medication unless advised to stop by your healthcare provider. Contact Pfizer Canada ULC for medical inquiries at 1-800-463-6001 or general inquiries at 1-800-387-4974. Report any health product-related side effects or complaints to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Increased cancer risk from long-term exposure
When was this product recalled?
This product was recalled on March 1, 2022.
Is the Inderal-LA brand affected by this recall?
Yes, Inderal-LA products are affected by this recall. This recall involves Inderal-LA (propranolol hydrochloride) extended release capsules sold in Canada. It's being recalled because of a nitrosamine impurity (N-nitroso-propranolol) above acceptable levels. Continue taking your medication unless advised otherwise by your healthcare provider, and contact them to discuss other treatment options.